Consistent with the Executive Order and to better attain the goals we have articulated in previous HPT rulemakingrequiring hospitals to make meaningful price information available to consumers, employers, policymakers, and others to support a more competitive, innovative, affordable, and higher quality healthcare systemin the CY 2026 OPPS/ASC proposed rule, CMS proposed several updates to the regulations at 45 CFR part 180
HMG Peptide: Human Menopausal Gonadotropin Explained HMG (menotropins) is an FDA-approved FSH+LH gonadotropin, not a true peptide
Long-Term Safety Considerations While 24-week human trials provide reassurance about short-to-medium term safety, very long-term data (multi-year continuous use) is limited
doi: 10.1016/j.ahj.2023.09.007
Progress in Biophysics and Molecular Biology, 140 , 512